2nd Quarter - Report

SQUIRE PATTON BOGGS for CSL BEHRING

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act Prescription Drug User Fee Act Reauthorization issues Orphan Drug Designation issues

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH SenatorMcCainIntern94-96;LSA96-97
JOHN JONAS —
ADRIANA KOHLER —
ERIC RASMUSSEN SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000

Contacted: SENATE

Bills named: H.R. 2672 (112th), S. 1423 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.